Skip to main content

Case Comprehensive Cancer Center

cancer-feat
Hero Type
Image
Turning on the ‘off switch’ in cancer cells
Scientists have identified binding pocket for molecules that can stabilize key braking mechanism in cancer—opening door to development of drugs that target it A team of scientists led by the Case Comprehensive Cancer Center and the University of Michigan Rogel Cancer Center has identified the bindi...
American Society of Clinical Oncology Annual Meeting 2020: Highlights from the Case CCC
The American Society of Clinical Oncology (ASCO) Annual Meeting will be held virtually in two parts this year. The Virtual Scientific Program will take place Friday, May 29 through Sunday, May 31 and the Virtual Education Program will take place August 8-10, 2020. Oral abstract, poster discussion an...
Lakeerie_Rockhall_Sciencemuseum_Brownsstadium.jpg
Hero Type
Image
Chan to Co-direct National Center for Regenerative Medicine
The National Center for Regenerative Medicine and Case Comprehensive Cancer Center announce the appointment of Timothy Chan, MD, PhD, cancer biology and immunogenomics expert, as co-director of the National Center for Regenerative Medicine. Dr. Chan is also Chair and Founding Director of the Center...
Director's Message: Return to Campus Life
Snow and rain on Mother’s Day; not my idea of a good time and I’m sure not yours either. We’ve all spent the last month inside Zooming around our research, education, institutions, departments and laboratories and their management issues, and I am sure we were all hoping for a better weekend. But ri...
Director's Message: Clinical Research Leadership Transition
The cancer center is delighted to announce that Mikkael Sekeres, MD, MS has been appointed Associate Director for Clinical Research for the Case Comprehensive Cancer Center (Case CCC). As Associate Director, Dr. Sekeres will oversee our entire portfolio of clinical trials, our translation of basic l...
Drupal-Aside-Photo.png
Hero Type
Image
Khorana appointed as Medical and Scientific Advisory Board Chair for the National Blood Clot Alliance
Please join us in extending congratulations to Alok Khorana, MD, professor of medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University on his recent appointment to Chair of the Medical and Scientific Advisory Board of the National Blood Clot Alliance (NBAC). Dr. Khoran...
Myeloid-derived Suppressor Cell Heterogeneity Comprises a Sex-specific Therapeutic Target for Glioblastoma
A study led by Justin D. Lathia, PhD (Bayik et al., Cancer Discovery, 2020) and conducted in collaboration with multiple Case Comprehensive Cancer Center member investigators (Ahmad M. Khalil, PhD; Tae Hyun Hwang, PhD; Manmeet S. Ahluwalia, MD and Feixiong Cheng, PhD) identified sex differences in a...
CanSUR scholar receives undergraduate Michelson-Morley Award
The Case Comprehensive Cancer Center extends congratulations to undergraduate Jack Kincaid on receiving first prize in the 2020 Michelson-Morley Research Competition in the Biological Sciences. Jack works in the lab of member Nathan Berger, MD, sponsored by the National Cancer Institute R25 Training...
Keri elected to Endocrine Society Board
The Case Comprehensive Cancer Center (Case CCC) extends congratulations to Ruth Keri, PhD, professor of pharmacology and Case CCC Associate Director for Basic Research on her recent election to the Board of Directors for the Endocrine Society. Dr. Keri will serve a three-year term for the society w...
esophagus
Hero Type
Image
Medical device developed by CWRU/UH researchers wins 2020 Edison Award
A medical device based on technology developed by three faculty members from Case Western Reserve University and University Hospitals Cleveland Medical Center (UH) has won a prestigious 2020 Edison Best New Product Award. EsoCheck, a device designed to help detect precancerous changes in the es...